| Tretinoin | Approved Investigational Nutraceutical | PPP1CB | 5500 |
downregulated | Tretinoin results in decreased expression of PPP1CB mRNA | 2p23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R13B | 23368 |
upregulated | Tretinoin results in increased expression of PPP1R13B mRNA | 14q32.33 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R13L | 10848 |
upregulated | Tretinoin results in increased expression of PPP1R13L mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R14A | 94274 |
downregulated | Tretinoin results in decreased expression of PPP1R14A mRNA | 19q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R16B | 26051 |
upregulated | Tretinoin results in increased expression of PPP1R16B mRNA | 20q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R17 | 10842 |
upregulated | Tretinoin results in increased expression of PPP1R17 mRNA | 7p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R18 | 170954 |
upregulated | Tretinoin results in increased expression of PPP1R18 mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R1A | 5502 |
downregulated | Tretinoin results in decreased expression of PPP1R1A mRNA | 12q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R3B | 79660 |
upregulated | Tretinoin results in increased expression of PPP1R3B mRNA | 8p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R3C | 5507 |
downregulated | Tretinoin results in decreased expression of PPP1R3C mRNA | 10q23.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R3C | 5507 |
upregulated | Tretinoin results in increased expression of PPP1R3C mRNA | 10q23.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP1R3D | 5509 |
upregulated | Tretinoin results in increased expression of PPP1R3D mRNA | 20q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP2R1B | 5519 |
downregulated | Tretinoin results in decreased expression of PPP2R1B mRNA | 11q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP2R2B | 5521 |
upregulated | Tretinoin results in increased expression of PPP2R2B mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP2R2D | 55844 |
downregulated | Tretinoin results in decreased expression of PPP2R2D mRNA | 10q26.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP2R5A | 5525 |
upregulated | Tretinoin results in increased expression of PPP2R5A mRNA | 1q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP2R5B | 5526 |
upregulated | Tretinoin results in increased expression of PPP2R5B mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP3CA | 5530 |
downregulated | Tretinoin results in decreased expression of PPP3CA mRNA | 4q24 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP4R4 | 57718 |
downregulated | Tretinoin results in decreased expression of PPP4R4 mRNA | 14q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PPP5C | 5536 |
upregulated | Tretinoin results in increased expression of PPP5C mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PPRC1 | 23082 |
downregulated | Tretinoin results in decreased expression of PPRC1 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PQLC2L | 152078 |
downregulated | Tretinoin results in decreased expression of PQLC2L mRNA | 3q25.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PQLC3 | 130814 |
downregulated | Tretinoin results in decreased expression of PQLC3 mRNA | 2p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PRAM1 | 84106 |
upregulated | Tretinoin results in increased expression of PRAM1 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PRCP | 5547 |
upregulated | Tretinoin results in increased expression of PRCP mRNA | 11q14 | |